Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

2015/12/10 by Gábor G. Kovács, Gabor G. Kovacs, Isidró Ferrer +86 · 33 citations
Medicine · #Alzheimer's disease research and treatments #Parkinson's Disease Mechanisms and Treatments #Neurological disorders and treatments

paper · doi:10.1007/s00401-015-1509-x

Citations

• Astrocytes: biology and pathology

Cited by

• Molecular pathology of neurodegenerative diseases: principles and practice
• Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies
• The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases
• Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)
• Astroglial atrophy in Alzheimer’s disease
• Celebrating 40 years of the University of Kentucky Alzheimer's Disease Research Center
• Making tau amyloid models <i>in vitro</i>: a crucial and underestimated challenge
• Primary retinal tauopathy: A tauopathy with a distinct molecular pattern
• Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine. [europepmc]
• "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). [europepmc]
• Neuropathological criteria of anti-IgLON5-related tauopathy. [europepmc]
• Repetitive Head Impacts and Chronic Traumatic Encephalopathy. [europepmc]
• Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players. [europepmc]
• Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. [europepmc]
• A systematic review of potential long-term effects of sport-related concussion. [europepmc]
• Stratification of astrocytes in healthy and diseased brain. [europepmc]
• Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study. [europepmc]
• Deciphering the Astrocyte Reaction in Alzheimer's Disease. [europepmc]
• The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome. [europepmc]
• TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. [europepmc]
• Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review. [europepmc]
• Extracellular Monomeric Tau Is Internalized by Astrocytes. [europepmc]
• The neuropathological diagnosis of Alzheimer's disease. [europepmc]
• Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes. [europepmc]
• Tau Protein and Its Role in Blood-Brain Barrier Dysfunction. [europepmc]
• Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia. [europepmc]
• Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. [europepmc]
• Cellular and pathological heterogeneity of primary tauopathies. [europepmc]
• Structure-based classification of tauopathies. [europepmc]
• Neuropathology of Alzheimer's Disease. [europepmc]
• Tauopathies: new perspectives and challenges. [europepmc]
• Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts. [europepmc]
• Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. [europepmc]